Suppr超能文献

特发性肺纤维化:诊断和管理的循证指南(美国胸科学会/欧洲呼吸学会/日本呼吸学会/拉丁美洲胸科学会联合发布)

An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management.

出版信息

Am J Respir Crit Care Med. 2011 Mar 15;183(6):788-824. doi: 10.1164/rccm.2009-040GL.

Abstract

This document is an international evidence-based guideline on the diagnosis and management of idiopathic pulmonary fibrosis, and is a collaborative effort of the American Thoracic Society, the European Respiratory Society, the Japanese Respiratory Society, and the Latin American Thoracic Association. It represents the current state of knowledge regarding idiopathic pulmonary fibrosis (IPF), and contains sections on definition and epidemiology, risk factors, diagnosis, natural history, staging and prognosis, treatment, and monitoring disease course. For the diagnosis and treatment sections, pragmatic GRADE evidence-based methodology was applied in a question-based format. For each diagnosis and treatment question, the committee graded the quality of the evidence available (high, moderate, low, or very low), and made a recommendation (yes or no, strong or weak). Recommendations were based on majority vote. It is emphasized that clinicians must spend adequate time with patients to discuss patients' values and preferences and decide on the appropriate course of action.

摘要

本文件是关于特发性肺纤维化诊断和管理的国际循证指南,由美国胸科学会、欧洲呼吸学会、日本呼吸学会和拉丁美洲胸科协会共同制定。它代表了目前关于特发性肺纤维化(IPF)的知识状况,内容包括定义和流行病学、危险因素、诊断、自然史、分期和预后、治疗以及监测疾病过程。对于诊断和治疗部分,采用基于问题的实用 GRADE 循证方法学。对于每个诊断和治疗问题,委员会对现有证据的质量进行分级(高、中、低或极低),并提出建议(是或否,强或弱)。建议基于多数票。需要强调的是,临床医生必须与患者充分沟通,讨论患者的价值观和偏好,并决定适当的治疗方案。

相似文献

6
Managing diagnostic procedures in idiopathic pulmonary fibrosis.特发性肺纤维化的诊断程序管理。
Eur Respir Rev. 2013 Jun 1;22(128):158-62. doi: 10.1183/09059180.00001213.
10
Recommendations on treatment for IPF.特发性肺纤维化治疗建议。
Respir Res. 2013;14 Suppl 1(Suppl 1):S6. doi: 10.1186/1465-9921-14-S1-S6. Epub 2013 Apr 16.

引用本文的文献

本文引用的文献

5
Prognostic factors in rapidly progressive interstitial pneumonia.快速进展性间质性肺炎的预后因素。
Respirology. 2010 Feb;15(2):257-64. doi: 10.1111/j.1440-1843.2009.01687.x. Epub 2010 Jan 11.
8
Pirfenidone in idiopathic pulmonary fibrosis.吡非尼酮治疗特发性肺纤维化。
Eur Respir J. 2010 Apr;35(4):821-9. doi: 10.1183/09031936.00005209. Epub 2009 Dec 8.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验